Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 30Genitourinary 25Other 13Lymphoid 13Thoracic 12Gastrointestinal 9Classical hematology 8Plasma cell 6Other hematologic neoplasm 6Head & Neck 6CNS 3NET 2Endocrine 2Dermatologic 2Sarcoma 1Myeloid 1Gynecologic 1

Conditions

Neuroendocrine Tumors 531Gastro-enteropancreatic neuroendocrine tumor 58Carcinoid Tumor 58Neoplasms 49Carcinoma, Neuroendocrine 44Pancreatic Neoplasms 36Adenoma, Islet Cell 33Neoplasm Metastasis 28Pheochromocytoma 25Colorectal Neoplasms 24Paraganglioma 23Stomach Neoplasms 21Breast Neoplasms 21Prostatic Neoplasms 20Lung Neoplasms 20Carcinoma, Hepatocellular 20Sarcoma 19Carcinoma 19Thyroid Neoplasms 18Gastrointestinal Neoplasms 18Neuroblastoma 15Cholangiocarcinoma 14Carcinoma, Renal Cell 14Small Cell Lung Carcinoma 13Melanoma 13Esophageal Neoplasms 13Serotonin Syndrome 12Colonic Neoplasms 12Brain Neoplasms 11Adenocarcinoma 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Heart Failure × NET × Clear all
NCT07450287 2026-03-04

CardioNETPOL

National Institute of Cardiology, Warsaw, Poland

Not yet recruiting
120 enrolled
EndocrineNET

Carcinoid Heart Disease, Heart Failure, Heart Valve Diseases, Neuroendocrine Tumors, Serotonin Syndrome

NCT01730417 2012-11-21

mIBG

Duke University

Phase 1 Completed
12 enrolled
EndocrineNET

Heart Failure, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡